Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MERTK as a novel therapeutic target in head and neck cancer.
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: sanders c. Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724. Oncotarget. 2016. PMID: 27081701 Free PMC article.
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.
von Mässenhausen A, Sanders C, Brägelmann J, Konantz M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Lengerke C, Perner S. von Mässenhausen A, et al. Among authors: sanders c. Int J Cancer. 2016 Nov 15;139(10):2359-69. doi: 10.1002/ijc.30279. Epub 2016 Jul 30. Int J Cancer. 2016. PMID: 27434411
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.
Brägelmann J, Klümper N, Offermann A, von Mässenhausen A, Böhm D, Deng M, Queisser A, Sanders C, Syring I, Merseburger AS, Vogel W, Sievers E, Vlasic I, Carlsson J, Andrén O, Brossart P, Duensing S, Svensson MA, Adler D, Kirfel J, Perner S. Brägelmann J, et al. Among authors: sanders c. Clin Cancer Res. 2017 Apr 1;23(7):1829-1840. doi: 10.1158/1078-0432.CCR-16-0094. Epub 2016 Sep 27. Clin Cancer Res. 2017. PMID: 27678455
Peer-to-peer validation of Ki-67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?
Bernhardt M, Weinhold L, Sanders C, Hommerding O, Lau JF, Toma M, Tischler V, Schmid M, Zienkiewicz T, Hildenbrand R, Gerlach P, Zhou H, Braun M, Müller G, Sieber E, Marko C, Kristiansen G. Bernhardt M, et al. Among authors: sanders c. APMIS. 2024 Oct;132(10):718-727. doi: 10.1111/apm.13451. Epub 2024 Jul 1. APMIS. 2024. PMID: 38951722
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.
Hommerding M, Hommerding O, Bernhardt M, Kreft T, Sanders C, Tischler V, Basitta P, Pelusi N, Wulf AL, Ohlmann CH, Ellinger J, Ritter M, Kristiansen G. Hommerding M, et al. Among authors: sanders c. World J Urol. 2024 Aug 22;42(1):491. doi: 10.1007/s00345-024-05188-7. World J Urol. 2024. PMID: 39172235 Free PMC article.
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.
Zeyen T, Friker LL, Paech D, Schaefer N, Weller J, Zschernack V, Layer JP, Schneider M, Potthoff AL, Bernhardt M, Sanders C, Kristiansen G, Hoelzel M, Gkika E, Radbruch A, Pietsch T, Herrlinger U, Schaub C. Zeyen T, et al. Among authors: sanders c. J Cancer Res Clin Oncol. 2024 Sep 28;150(9):437. doi: 10.1007/s00432-024-05963-4. J Cancer Res Clin Oncol. 2024. PMID: 39340558 Free PMC article.
1,696 results